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Abstract
Background: The growing trend of breast cancer in Iran and the adverse consequences arising from the delay in diagnosis and
treatment in females has been a challenge.
Objectives: This study was conducted to identify the predictors for diagnosis and treatment delay in females with breast cancer in
the north of Iran.
Methods: This cross-sectional study was performed on 232 patients with a definite diagnosis of breast cancer at Razi Hospital, which
is the main referral centre in Guilan Province, Iran, using sequential sampling methods. Data were collected using a six-section ques-
tionnaire through interviews and medical records of the patients. Data were analyzed using descriptive statistics, logistic regression
and chi square test.
Results: Delays of more than one month was observed in 53% of patients and more than three months delay was observed in 31%. Of
the patients with a definite diagnosis of breast cancer, 87% returned within seven days for treatment interventions. Three variables
of: stage of disease (stage II: P = 0.002, OR = 7.19 and stage III: P = 0.034, OR = 1.95), lack of complementary insurance (P = 0.007, OR =
2.26) and primary insurance (P = 0.067, OR = 3.52) were important risk factors for patient delay. Knowledge and attitude regarding
the symptoms of breast cancer (P = 0.007), the most important method for breast cancer diagnosis (P = 0.004), and the importance
of self-examination was significantly different between patients with and without delay in the onset of treatment.
Conclusions: This study showed that about one-third of patients with breast cancer had a patient delay of more than three months.
In addition, 16.8% and 13% of patients experienced system delay in diagnosis and treatment, respectively. The government is respon-
sible to not only teach people on the signs of breast cancer, but also to establish a powerful screening system for breast cancer.
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1. Background
Breast cancer is the most common malignancy in fe-
males (1) and a concerning public health problem (2). In
the United States (US), it is responsible for one out of every
three diagnosed malignancies in females (3). Its incidence
is also increasing in developing countries (4, 5) including
Iran, so that about 5,000 new cases are diagnosed annu-
ally (6). Unfortunately most cases are detected at more ad-
vanced stages and at lower ages in comparison with west-
ern countries (7, 8). Some studies from Iran have attributed
the problem to a lack of education and lack of a regular
screening program and a delay in diagnosis and receiving
medical treatment (9, 10).
Such a delay might be categorized to patient delay and
healthcare provider (system) delay. The interval between
detection of the first symptoms by the patient and the first
physician visit is known as patient delay (11), however, the
interval between the first visit and receiving treatment is
regarded as the system delay (12). Any delay in diagnosis
and treatment can result in disease progression, increased
mortality, and decreased survival rate (5, 13, 14)
Several studies are available on the reasons for patient
delay and a number of factors such as patients’ low knowl-
edge and education, low socioeconomic status, and family
history of breast cancer have been cited in this regard (15-
18). However, sociocultural aspects of cancer treatment or
cancer treatment seeking behaviors might be different in
developing countries (13), and these two factors play an im-
portant role in timely diagnosis and treatment. One of the
nurse′s roles as educators of health behaviors should be to
promote true beliefs and attitudes in relation to breast can-
cer and its treatment in the general population (19, 20).
Recently, Khakbazan et al. investigated the help seek-
ing behaviors of females with self-discovered breast cancer
symptoms in Iran (21). However, no comprehensive stud-
ies are available on sociocultural aspects of breast cancer
treatment and the breast cancer patients’ treatment seek-
ing behaviors in Iran.
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2. Objectives
This study was conducted on breast cancer patients re-
ferred to Razi educational and treatment center, north of
Iran, to identify the causes of patient and system delay in
diagnosis and the treatment of breast cancer.
3. Materials and Methods
3.1. Study Design
This cross-sectional study was performed from Septem-
ber to November 2013 on patients with a definite diagnosis
of breast cancer, who had referred for check up, to the Razi
hospital in Rasht city. This is the main referral and govern-
mental center for cancer chemotherapy and radiotherapy
in Guilan Province with coverage of all insurance compa-
nies.
3.2. Sampling
In a recent study, Harirchi et al. reported that 68% of
Iranian breast cancer patients had a delay of more than
one month (13). Then, with a type I error of 0.05, P = 0.68
and sampling error of 0.06, a total of 232 subjects were re-
cruited in the study. A sequential sampling method was
used to identify the samples. Inclusion criteria were a defi-
nite diagnosis of cancer within the last two years, and will-
ingness to participate in the study.
3.3. Measurement and Data Collection
Using the Harirchi et al. questionnaire (13) a six-section
instrument was developed. The first part comprised of
eight questions on patients’ age, place of residence, edu-
cation level, marital status, average monthly income, num-
ber of children, and the status of primary and complemen-
tary insurance. The second part included eight questions
related to family history of breast cancer, type of family
relationship between the patient and the family member
with a history of breast cancer, history of performing mam-
mography before the onset of illness, number of mam-
mography examinations (once a year, every six months),
attending regular physician visits, the first symptom of the
tumor, the interval between the first suspicious symptom
and the first medical consultation, and the first person the
patient was referred to. The third part consisted of three
items on patients’ knowledge and four items on her atti-
tude toward breast problems. These items are scored based
on their frequencies. The fourth section was a checklist
on disease stage, tumor size, and treatment status, which
were derived from the patients’ records. The fifth part con-
sisted of 10 questions for assessing the causes of patient de-
lay and the sixth section consisted of three questions on
the causes of system delay. An interval of more than one
month between detection of the first symptoms by the pa-
tient and the first medical consultation was regarded as pa-
tient delay. Moreover, the time between the first consul-
tation with a physician and the start of treatment was re-
garded as the provider/system delay.
To determine the validity of the questionnaire, it was
evaluated by ten experts in this field. Test-retest method
with a two-week interval was also conducted for 30 pa-
tients to evaluate the reliability of the questionnaire (r =
0.91). Questionnaires were completed through face-to-face
interviews when the patients attended the oncology and
radiotherapy clinic of Razi hospital for check up.
3.4. Ethical Considerations
This study was approved by the Ethics Committee of
Research Deputy, of Guilan University of Medical Sciences
(grant number = 481). Written informed consent was ob-
tained from all participants at the beginning of the study.
All participants were informed of the voluntary nature of
participation and were assured about the confidentiality
of their personal information.
3.5. Data Analysis
SPSS-13 software (Spss Inc, Chicago, IL, USA) was used
for data analysis. First, data was analyzed descriptively us-
ing frequency, mean and standard deviation indices. Fac-
tors affecting patient delay were also studied through uni-
variate logistic regression, and odds ratio was determined.
Having a delay was considered as a dependent variable and
other variables were considered as factors (i.e. age, (< 40
years, 40 - 50 and > 50 years) including, status of residence
(urban, village), education (illiterate, primary education,
high school diploma and academic degrees), marital sta-
tus (single, married and widowed/divorced), number of
children (0, 1 - 3 and 4 <), monthly incomes, having an ac-
tive insurance (yes , no), having complementary insurance
(yes , no), family history of breast cancer (yes , no), history
of performing a mammography (yes , no) and stage of dis-
ease (I, II and III). Variable with P values of ≤ 0.2 were en-
tered in the multivariate logistic regression model (i.e. ed-
ucation, having an insurance, having complementary in-
surance, family history of breast cancer, history of mam-
mography and stage of disease). Chi-square was also used
to evaluate the relationship between delay and patients’
knowledge and attitude. P values of less than 0.05 were
considered statistically significant.
4. Results
In this study, 113 patients (48.7%) were above 50 years
of age. The mean age was 49.82 ± 10.23 years. They were
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mostly (85.5%) married and had elementary school edu-
cation (3707%). In logistic regression, only having an ac-
tive insurance, having complementary insurance and his-
tory of performing mammography, were predictive (pre-
ventive factor) for patient delay. Moreover, a significant re-
lationship was observed between the disease stage and the
delay (Table 1).
Sixty percent (n = 129) of the patients had a tumor
larger than 5 cm and 46% had lymph node involvement at
the time of diagnosis.
The disease was detected through breast self-
examination (BSE) in 211 patients (91%) and finding a
lump was the first symptom for visiting the physician in
66% of the patients. Pain (19.8%), ulceration (1.3%), nipple
discharge and bleeding (2.6%) and asymmetric breasts
(4.7%) were other symptoms that resulted in a diagnosis
of cancer in the rest of the patients. Moreover, 44.8%
and 37.1% of the patients visited a general surgeon and a
gynecologist on their first visit, respectively. In total, 123
patients (53%) had a delay of more than one month and
31% had a delay of more than three months in their first
visits. The mean patient delay was 117.53± 238.82 days with
a median of 21 days.
In multivariate logistic regression, two variables of
complementary insurance (P = 0.007, OR = 2.260) and pri-
mary insurance coverage (P = 0.06, OR = 3.521) were impor-
tant preventive factors for patient delay, so that patient de-
lay was lower in those with complementary and primary
insurance coverage. In addition, the ratio of delay was 7.188
and 1.948 times more in the second and third stages of the
disease in comparison with patients in the first (Table 2).
Moreover, significant differences were observed be-
tween patients with and without delay in terms of knowl-
edge of the signs of breast cancer (P = 0.007), the most com-
mon cancers in women (P = 0.004), the most important
methods for the diagnosis of breast cancer (P = 0.004), atti-
tude towards breast cancer (P = 0.009), importance of BSE
(P = 0.03) and familiarity with the techniques of BSE (P =
0.04) (Table 3).
In the provider/system delay part, 16.8% of cases (n = 39)
had a delay between the diagnosis and biopsy examination
with a mean of 160.02± 192.40 days and 13.0% (n = 30) had
a delay between biopsy examination and treatment with a
mean of 114.81± 240.08 days (Table 4).
According to the patients, the most important reasons
for a patient delay of more than one month were feeling no
urgency to see a physician (32.7%), fear of the disease and





























Figure 1. Reasons for the Patient Delay
5. Discussion
In the present study, 53% and 31% of the patients with
breast cancer reported a patient delay of less than one
month and more than three months, respectively. The
rate of delay in the present study was somewhat less than
what was reported by a previous study in Iran (22). How-
ever, patient delay was more in our study when compared
with other countries such as Thailand (17.0%) (23), Colom-
bia (20.3%) (2) and the United States (17.0%) (24).
Based on the results of the present study, lack of in-
surance, specially lacking a complementary insurance was
an important risk factor for patient delay particularly in
low-income patients. Therefore, it is necessary for health
insurance programs to cover the cancer diagnostic exam-
inations and treatment procedures. Moreover, similar to
other studies (23, 25, 26), low education level and low in-
come were risk factors for patient delay. So that more low-
income patients referred to physicians in stage III. These
findings were consistent with previous studies (3, 27, 28).
In the present study, 60% of patients had a tumor
larger than 5 cm and 46% had lymph node involvement
at the time of diagnosis, which apparently showed the de-
lay. Moreover, only a few patients had a previous history
of mammography screening while the risk of delay was
lower in patients with a history of mammography, which
indicates the role of mammography in early diagnosis and
treatment of breast cancer. In addition, only 41.4% of our
patients were familiar with BSE. All these findings not only
confirmed the females’ low knowledge on the importance
of BSE and screening tests but also showed the weak per-
formance of the healthcare system in community educa-
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Table 1. The Result of Univariate Logistic Regression Analysis on Patient Delaya
Predictive Variable Delay Univariate Analysis
Yes No OR (95% CI) P Value
Age, y
< 40 17 (13.8) 14 (12.8) 1 (Baseline)
40 - 50 43 (35.0) 45 (41.3) 1.27 (0.56 - 2.89) 0.568
> 50 63 (51.2) 50 (45.9) 0.96 (0.43 - 2.14) 0.928
Place of residence 0.321
Urban 77 (62.6) 75 (68.8) 1 (Baseline)
Village 46 (37.4) 34 (31.2) 1.32 (0.76 - 2.27)
Education level
Illiterate 35 (28.5) 15 (13.8) 0.34 (0.11 - 1.04) 0.059
Primary education 44 (35.8) 42 (38.5) 0.76 (0.27 - 2.12) 0.605
High school diploma 36 (29.2) 42 (38.5) 0.93 (0.33 - 2.61) 0.896
Academic Degrees 8 (6.5) 10 (9.2) 1 (Baseline)
Marital status
Single 7 (5.7) 5 (4.6) 1 (Baseline) 0.966
Married 103 (83.7) 95 (87.2) 1.03 (0.25 - 4.31) 0.530
Widowed/divorced 13 (10.6) 9 (8.3) 1.33 (0.25 - 3.26)
Number of Children
No children 10 (8.1) 9 (8.3) 1 (Baseline) 0.935
1 - 3 79 (64.2) 74 (67.9) 1.04 (0.40 - 2.71) 0.758
4 < 34 (27.6) 26 (23.9) 0.85 (0.30 - 2.39)
Monthly income (Rls)
< 5,000,000 75 (61.0) 45 (41.3) 0.60 (0.12 - 3.10) 0.542
5,000,000 - 7,500,000 38 (30.9) 47 (43.1) 1.24 (0.24 - 6.48) 0.801
7,500,000 - 10,000,000 7 (5.7) 14 (12.8) 2.00 (0.32 - 12.59) 0.460
10,000,000 < 3 (2.4) 3 (2.8) 1 (Baseline)
Having an insurance coverage 0.029
Yes 110 (89.4) 106 (97.2) 1 (Baseline)
No 13 (10.6) 3 (2.8) 4.17 (1.16 - 15.07)
Having complementary insurance 0.006
Yes 38 (30.9) 53 (48.6) 1 (Baseline)
No 85 (69.1) 56 (51.4) 2.18 (1.24 - 3.62)
Family history of breast cancer 0.059
Yes 24 (19.5) 33 (30.3) 1.79 (0.98 - 3.28)
No 99 (80.5) 76 (69.7) 1 (Baseline)
History of mammography 0.01
Yes 10 (8.1) 22 (20.2) 0.35 (0.16 - 0.78)
No 113 (91.9) 87 (79.8) 1 (Baseline)
Stage of disease
I 4 (3.3) 14 (12.8) 1 (Baseline)
II 69 (56) 67 (61.5) 6.25 (1.87 - 20.83) 0.003
III 50 (40.7) 28 (25.7) 1.73 (0.98 - 3.07) 0.059
a Values are expressed as No. (%).
Table 2. The Result of Multivariate Logistic Regression Analysis on Patient Delay
Predictive Variable S.E. Wald P Value OR (95% CI)
Primary insurance (No) 0.69 3.35 0.067 3.52 (0.91 - 13.46)
Complementary insurance (No) 0.30 7.40 0.007 2.26 (1.25 - 4.05)
Family history of breast cancer (No) 0.33 2.79 0.095 1.74 (1.09 - 3.32)
History of mammography (No) 0.44 2.96 0.085 2.11 (0.88 - 5.00)
Stage of disease
Stage I (Baseline) 10.58 0.005 -
Stage II 0.65 9.24 0.002 7.19 (2.01 - 25.80)
Stage III 0.31 4.51 0.034 1.95 (1.06 - 3.56)
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Table 3. Knowledge and Attitude Towards Breast Cancera
Phrases Delay P Value
No Yes
Knowledge of Breast Cancer Symptoms 0.007
Breast and axillary lump 42 (38) 38 (31)
Lump and other symptoms 24 (22) 13 (11)
I do not know 43 (40) 72 (58)
Knowledge of most common cancers in women 0.004
Breast cancer is the most prevalent cancer in females 72 (66) 55(45)
Another cancer except Breast cancer, is the most prevalent cancer 2 (2) 6 (5)
I don’t have any information 35 (32) 62 (50)
The most important method for the diagnosis of breast cancer 0.004
Breast self-examination 42 (38) 29 (23)
Physician 38 (35) 58 (48)
Mammography 24 (22) 21 (17)
Blood tests 4 (4) 3 (2)
I do not know 1 (1) 12 (10)
Attitude towards breast cancer 0.009
Breast cancer is curable 82 (75) 67 (54)
Breast cancer is fatal 4 (4) 8 (7)
It depends on individual’s fate 15 (14) 36 (29)
I don’t have any information 8 (7) 12 (10)
Importance of self-examination 0.03
Breast self-examination is important 62 (57) 53 (43)
Breast self-examination is unimportant 47 (43) 70 (57)
Familiarity with self-examination 0.04
Yes 52 (47) 44 (36)
No 57 (53) 79 (64)
Total 109 (100) 123 (100)
a Values are expressed as No. (%).
Table 4. The Reasons for Delay in Treatment and Diagnostic Procedure After Visiting the Physician
Variable of Provider/System Delay No. (%)
Diagnostic procedures 7 days after visiting the physician
Yes 194 (83.2)
No 39 (16.8)
Reasons for not doing the diagnostic procedures
Lack of access to mammography / sonography 2 (0.9)
Assurance of the physician that the symptoms were not important 32 (13.8)
Waiting on the list for specialist physicians 5 (2.2)
Treatment within 7 days of definite diagnosis
Yes 202 (87)
No 30 (13)
Reasons for not doing treatment procedures
Lack of access to chemotherapy and radiotherapy 2 (1)
Costs of treatment 10 (4.5)
Loss of time for the patient insurance 1 (0.5)
Waiting on the list for treatment 17 (7)
tion and in disease screening. Previous studies in Iran have
shown that the rate of BSE is as low as 6% - 17% (8, 29, 30).
Consistently, a study in Colombia reported that 24.5% of
the women in the age group 18 - 69 years performed BSE
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regularly (2). However, this rate is 75% among US women
(31), which is clearly different from developing countries.
Although the patients related factors such as low socioe-
conomic status, low education level, and lack of knowl-
edge regarding breast cancer and BSE are usually cited as
the most important reasons for female’s weak practice in
BSE, however, the weak performance of the governmental
healthcare systems should not be overlooked.
In this study, the majority of patients (58% and 40% of
the patients with and without delay) had no information
about the symptoms of cancer. Moreover, 43% and 57% of
the patients with and without delay were not aware of the
importance of self-assessment. Moreover, only a few pa-
tients were aware of the role of mammography in screen-
ing for breast cancer. These findings are in line with the re-
sults of the previous studies in Iran (8, 32) and in other de-
veloping countries (2, 33, 34). A previous study emphasized
on the role of the media (8) and education systems in mak-
ing people, and especially all women above 20 years of age,
familiar with the symptoms of breast cancer and BSE (35).
However, despite the striking fact of Iran’s rank in breast
cancer, there is still no organized screening program for
breast cancer in Iran.
The present study showed a significant relationship be-
tween patient delay and disease stage at the time of diag-
nosis so that patients with delay were mostly at advanced
stages at the time of diagnosis. This finding was consistent
with what was reported by previous studies (2, 12).
In the present study, the most important reasons for
patient delay were feeling no urgency to see the physician,
minimizing and trivializing the symptoms of the disease,
financial concerns, and fear of incurability. Other studies
from Iran (22, 36) and other developing countries (2, 33)
have also reported similar findings. Moreover, the results
of studies on patients with various cancers showed that in-
correct interpretation and trivializing the symptoms and
fear of visiting a physician were important reasons for pa-
tient delay (37, 38). These findings again confirm the pa-
tients’ low knowledge about the symptoms of breast can-
cer and its effect of their treatment seeking behavior. Fear
of incurability may not only keep patients from seeking
medical treatment despite certain changes in their body,
but also may keep them from searching for information
(20, 39).
System delay comprised a great proportion of delays in
the present study, so that assurance of the physician that
the symptoms were not important was the reason for de-
tecting breast cancer at more advanced stages in 13.8% of
the cases. Moreover, waiting on the list for chemother-
apy and radiotherapy comprised 7% of the reasons for de-
lay. The reason could be that there is only one governmen-
tal center with chemotherapy facilities in Guilan Province,
north of Iran. Bilimoria et al. also reported an increase in
the interval between the diagnosis and treatment of can-
cers due to the increase in the load of cancers (40).
One of the limitations of this research that can be
noted is gathering samples at a governmental center. Also,
evaluation of system delay through assessing only three
variables can be considered as a research limitation.
Further multicenter studies with larger sample sizes
and inclusion of patients referring to the private sys-
tem are suggested. Moreover, designing improved instru-
ments for assessing knowledge and attitude of patients
and also considering the time period during which pa-
tients have refused treatment initiation, as part of the rea-
son of system delay is recommended.
In conclusion, this study showed that about one-third
of patients with breast cancer had a patient delay of more
than three months. In addition 16.8% and 13% of patients
experienced system delay in diagnosis and treatment, re-
spectively. Amongst the investigated factors, lack of in-
surance coverage and specially lacking a complementary
insurance, low education level and low income were risk
factors for patient delay. Considering the results of the
present study, the government is responsible to establish
an organized screening program for breast cancer nation-
wide. The government and also all education systems are
also responsible to not only teach people about the signs
of breast cancer, but also to establish a continues public
training system to educate all girls and women on the im-
portance and methods of regular screening of breast can-
cer such as BSE and mammography. Moreover, the gov-
ernment is responsible to provide insurance for all people
and also it is necessary for health insurance programs to
cover cancer diagnostic examinations and treatment pro-
cedures.
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